NPR logo
High Drug Costs: Industry Perspective
  • Download
  • <iframe src="https://www.npr.org/player/embed/4113399/4113400" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
High Drug Costs: Industry Perspective

Health Care

High Drug Costs: Industry Perspective

High Drug Costs: Industry Perspective
  • Download
  • <iframe src="https://www.npr.org/player/embed/4113399/4113400" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

NPR's Jennifer Ludden talks with Dr. Paul Antony, chief medical officer for the Pharmaceutical Research and Manufacturers of America. He offers the drug industry's perspective on the rising costs of prescription drugs, and responds to charges made Saturday by Dr. Marcia Angell, who accuses pharmaceutical companies of spending too much on advertising and making undue profits.

Related NPR Stories

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.